Evidence map›Paper›PMID 31292334›Full record

ArticleThe Journal of veterinary medical science2019

Actinobacillus species isolated from Japanese Thoroughbred racehorses in the last two decades.

Eri Uchida-Fujii, Hidekazu Niwa, Yuta Kinoshita, Toshio Nukada

Open access · diamondAbstract read
In one paragraph

Article in The Journal of veterinary medical science, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Eri Uchida-FujiiMicrobiology Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi 329-0412, Japan.
Hidekazu NiwaMicrobiology Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi 329-0412, Japan.
Yuta KinoshitaMicrobiology Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi 329-0412, Japan.
Toshio NukadaMicrobiology Division, Equine Research Institute, Japan Racing Association, Shimotsuke, Tochigi 329-0412, Japan.
Japan Racing Association · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Actinobacillus species are known to be pathogenic to horses. To clarify etiological agents of actinobacillosis in Japanese adult horses, 27 isolates from Japanese Thoroughbred racehorses putatively identified by matrix-assisted laser desorption ionization time-of-flight mass spectrometry as Actinobacillus were further identified by PCR of the A. equuli toxin gene, by CAMP test, and by 16S rRNA sequencing analysis. Actinobacillus equuli subsp. haemolyticus was isolated most frequently (16/27) and was related to respiratory infections. Actinobacillus equuli subsp. equuli (4/27) was isolated from chronic cases or concomitant with other bacterial infections. The remainder were A. pleuropneumoniae, unclassified Actinobacillus species and Pasteurella caballi. Actinobacillus equuli including subsp. haemolyticus and subsp. equuli were the species most frequently isolated from equine actinobacillosis in Japan.

Indexed as

ActinobacillusActinobacillus InfectionsAnimalsBacterial ProteinsDNA, BacterialHorse DiseasesHorsesJapanPasteurellaPolymerase Chain ReactionRNA, Ribosomal, 16SSpectrometry, Mass, Matrix-Assisted Laser Desorption-IonizationBacterial ProteinsDNA, BacterialRNA, Ribosomal, 16S16S rRNAActinobacillusmatrix-assisted laser desorption ionization-time-of-flight mass spectrometry (MALDI-TOF MS)repeats-in-toxin (RTX)Thoroughbred

Identifiers

PMID31292334
PMCPMC6785623
OpenAlexW2960443099

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.